Please enable it to take advantage of the complete set of features! RRd::||7?_EeYU2&*[-%yWU0J@eZZ+)_P2B A_`T The total amount of INFeD required for the treatment of iron deficiency anemia or iron replacement for blood loss is determined from the table or appropriate formula (See Dosage). 5 0 obj 2007 May;10(3):311-7. doi: 10.1097/MCO.0b013e3280ebb427. If the patient is standing, he/she should be bearing his/her weight on the leg opposite the injection site, or if in bed, he/she should be in the lateral position with injection site uppermost. Each mL contains the equivalent of 50 mg of elemental iron (as an iron dextran complex), approximately 0.9% sodium chloride, in water for injection. (See Sensitivity Testing under Dosage and Administration.) official website and that any information you provide is encrypted Following administration of Infed, circulating iron dextran is split by the cells of the reticuloendothelial system into its components of iron and dextran. 0000001168 00000 n Possible fever and exacerbation or reactivation of joint pain and swelling with IV administration in patients with rheumatoid arthritis; use with extreme caution. INFeD should be injected only into the muscle mass of the upper outer quadrant of the buttock - never into the arm or other exposed areas - and should be injected deeply, with a 2-inch or 3-inch 19 or 20 gauge needle. Evaluation of the stability of vancomycin solutions at concentrations Calculate the Infed dose based upon the formula below which is based upon the approximate amount of blood loss and pretreatment hematocrit. 0000007316 00000 n Adverse pregnancy outcomes associated with IDA include increased risk for preterm delivery and low birth weight. [Progress in drug technology in the years 1968 and 1969]. Medically reviewed by Drugs.com on Oct 25, 2022. If there is no reaction after 1 hour continue. Stability of aminophylline injection in three parenteral nutrient solutions. 12.2 Pharmacodynamics Use Infed only in patients in whom clinical and laboratory investigations have established an iron deficient state not amenable to oral iron therapy. For males: LBW = 50 kg + 2.3 kg for each inch of patients height over 5 feet Oxford University Press is a department of the University of Oxford. 12.3 Pharmacokinetics . Stability of solutions of antineoplastic agents during preparation and storage for in vitro assays. In patients with chronic kidney disease (CKD) on hemodialysis, IV iron superior to orally administered iron for increasing hemoglobin concentrations and/or minimizing dosage of an erythropoiesis-stimulating agent (ESA); the National Kidney Foundation Kidney Disease Outcomes Quality Initiative (NKF-KDOQI) guidelines state that the IV route is preferred for iron administration in such patients. Removal of Iron Dextran by Hemodialysis: An In Vitro Study. Available for Android and iOS devices. All pregnancies have a background risk of birth defects, loss, or other adverse outcomes. 0000000016 00000 n 8.1 Pregnancy Risk for anaphylaxis may be increased in patients with history of drug allergy or multiple drug allergies or with concomitant use of ACE inhibitors. Skin and subcutaneous disorders: Urticaria, pruritus, purpura, rash, sweating. Infusion should then be stopped for 1 hour. PDF INFeD See full prescribing information for complete boxed warning H|TMs6Wu*Q6i\l.` (See Boxed Warning.) This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. w:Z7LWT0 CIu:rz9;y| Nd'T 4'" \py?_%XySt[]O!8cf}Uhi6yf^r={qK"P-CspB_z%k6cCJbDKmE![V 1984 Mar;19(3):202, 207, 211-3. Importance of informing clinicians of existing or contemplated concomitant therapy, including prescription and OTC drugs, as well as concomitant illnesses. Stability of injectable medications after reconstitution CAREFULLY BEFORE ACCESSING OR USING THIS SITE. Do Not Copy, Distribute or otherwise Disseminate without express permission. Metabolism S39(,``sS*|JmdcA#C-"J1GSNqH4r~INF!F!39$*Lcc$,4 (x((C!GvFL|N@2 xY@C`&6[lLf9YODqV,&$tbz*OJ%]. It should be recognized that iron storage may lag behind the appearance of normal blood morphology. The easiest-to-prepare dilute solution (iron dextran, benzyl alcohol, and sterile water for injection) was stable for three months; stability was greater when refrigerated. There are two preparations of IV iron available; IV iron sucrose (Venofer) given as divided dosages, and low molecular weight iron dextran (CosmoFer) this can be given as divided dose or as a total dose infusion (CosmoFer may also be given intramuscularly). 5 If reconstituted vaccine is not used immediately or comes in a multidose vial, be sure to clearly mark the vial with the date and time the vaccine was reconstituted, maintain the product at 2-8C (36-46F); do not freeze, and use only within the time indicated on chart above. The https:// ensures that you are connecting to the Therefore, administration of subsequent test doses during therapy should be considered. 0000032198 00000 n Before To calculate a patient's weight in kg when lbs are known: 2.3 Recommended Dosage of Iron Replacement for Blood Loss Total iron and free ferrous ion content of the preparations were measured for: (1) the dilute solutions at monthly intervals after up to three months of storage at room temperature and under refrigeration and (2) the parenteral nutrient solutions after 18 hours of storage at room temperature. Subscribe to Drugs.com newsletters for the latest medication news, new drug approvals, alerts and updates. Women's Bond NFT Collection 4 0 obj a Abciximab (reopro) Acetaminophen Acetazolamide (Diamox ) 0000036781 00000 n Iron dextran was stable in the four parenteral nutrient solutions after 18 hours of room-temperature storage. In patients with CKD receiving an ESA, administer sufficient iron to maintain selected targets of iron therapy (i.e., transferrin saturation and serum ferritin concentrations); periodically monitor these iron indices and use results (in conjunction with hemoglobin concentrations and ESA dosage) to guide iron therapy. Discontinue administration of any iron-containing products prior to administration of Infed. 0000004132 00000 n IV Iron Dextran Infusion Protocol | MedStar Health Chemical and physical bases determining the instability and incompatibility of formulated injectable drugs. 0000002441 00000 n The https:// ensures that you are connecting to the Hb```f`` l,/`"`FOB/r7}UL 0000008737 00000 n Federal government websites often end in .gov or .mil. All rights reserved. 0000003686 00000 n Advise patients to immediately report any symptoms of hypersensitivity that develop during and following Infed administration such as arthralgia, backache, chills, dizziness, moderate to high fever, headache, malaise, myalgia, nausea, and vomiting [see Warnings and Precautions (5.1)]. Assess baseline hematologic (hemoglobin and hematocrit) and iron storage parameters (serum iron, total iron binding capacity, and percent saturation of transferrin) to monitor response to therapy. CAS number: 9004-66-4. Possible risk of carcinogenesis associated with IM administration of iron-carbohydrate complexes. used within 6 hours after reconstitution.If RZV is stored after reconstitution, store at recommended storage conditions and reagitate prior to administration. The PubMed wordmark and PubMed logo are registered trademarks of the U.S. Department of Health and Human Services (HHS). Parenterally administered iron does not give a faster response compared to oral administration, therefore, the rate of recovery from anemia should be the same. COMMENTARY Biological parenteral products ar - American Society of 88 0 obj<>stream endstream endobj 57 0 obj<> endobj 58 0 obj<>stream 0000002294 00000 n Use with caution in patients with a history of clinically important allergies and/or asthma. Neither GlobalRPh Inc. nor any other party involved in the preparation of this document shall be liable for any special, consequential, or exemplary damages resulting in whole or part from any user's use of or reliance upon this material. 0 $]: Infed is contraindicated in patients who have demonstrated a previous hypersensitivity to iron dextran [see Warnings and Precautions (5.1)]. Risk Summary Attached to this memorandum is a copy of a package insert for iron dextran (Infed). 218 0 obj << /Linearized 1 /O 220 /H [ 1168 873 ] /L 336009 /E 11783 /N 28 /T 331530 >> endobj xref 218 36 0000000016 00000 n Would you like email updates of new search results? Clipboard, Search History, and several other advanced features are temporarily unavailable. Importance of informing patients of other important precautionary information. Improper storage conditions after reconstitution will lead to the administration of a subtherapeutic medication and will eventually lead to treatment failure and antibiotic resistance. Generic name: iron dextran Am J Kid Dis. A subsidiary of Watson Pharmaceuticals, Inc. Unauthorized use of these marks is strictly prohibited. 0000013948 00000 n 0000002041 00000 n 0 Based on: Desired Hb = the target Hb in g/dl. Adverse reactions experienced following administration of Infed may exacerbate cardiovascular complications in patients with pre-existing cardiovascular disease. Trace amounts of unmetabolized iron dextran are present in human milk. This total iron requirement reflects the amount of iron needed to restore hemoglobin concentration to normal or near normal levels plus an additional allowance to provide adequate replenishment of iron stores in most individuals with moderately or severely reduced levels of hemoglobin. Use Infed only in patients in whom clinical and laboratory investigations have established an iron deficient state not amenable to oral iron therapy. 0000037333 00000 n WARNING: RISK FOR ANAPHYLACTIC-TYPE REACTIONS Infed (iron dextran injection USP) containing 50 mg of elemental iron per mL, is available as a dark brown, slightly viscous, sterile solution in 2 mL single-dose amber vials in cartons of 10 (NDC 0023-6082-10). (See Anaphylaxis under Cautions.) Medical Communications Large doses of iron dextran (5 mL or more) have been reported to give a brown color to serum from a blood sample drawn 4 hours after administration. Infed is given undiluted at a slow gradual rate not to exceed 50 mg (1 mL) per minute. The stability of injectable medications after reconstitution is presented. Parenteral Iron Therapy Options - Wiley Online Library If no adverse reactions are observed, INFeD can be given according to the following schedule until the calculated total amount required has been reached. Do not mix with other drugs or add to parenteral nutrition solutions for IV infusion. Stability of acyclovir sodium after reconstitution in 0.9% sodium chloride inje ction and storage in polypropylene syringes for pediatric use. Administer the test dose at a gradual rate over at least 30 seconds. Solution Stability: VIDAZA reconstituted for intravenous administration may be stored at 25C (77F), but administration must be completed within 1 hour of reconstitution. (See package insert for PRECAUTIONS: Pediatric Use), Alternatively the total dose may be calculated: F'T9CQU!haSuYn5yd)}^O:Cu) ^>?9#f+R' Federal government websites often end in .gov or .mil. 0000003224 00000 n Intravenous or intramuscular injections of INFeD are indicated for treatment of patients with documented iron deficiency in whom oral administration is unsatisfactory or impossible.. 8.2 Lactation Protect from light. HdTr0+(R^ m$K~*&S)j5-Df"F d (8-s)h#=xF9+47{%CDQ$EMDH7x$k"$>~ynvloopxfG? Int J Pharm Compd. The study suggests that addition of recommended daily doses of iron dextran to parenteral nutrient solutions creates no stability problems; however, further study of the effects of temperature, pH, light, and storage time are recommended. Treatment of iron deficiency when oral iron preparations are ineffective or cannot be used. Obstetric clinical pharmacy: A necessary birth of a new specialty, Sister Mary Louise Degenhart dies at 85 years, Infection risk and management strategies for patients with cirrhosis taking proton pump inhibitors, Cold chain experts look to future during latest ASHP forum, National trends in prescription drug expenditures and projections for 2023, ASHP National Surveys of Pharmacy Practice in Hospital Settings, Population Health Management Theme Issues, Practice Advancement Initiative Collection, Transitions of Care/Medication Reconciliation, Emergency Preparedness and Clinician Well-being, Author Instructions for Residents Edition, Receive exclusive offers and updates from Oxford Academic, Copyright 2023 American Society of Health-System Pharmacists. 0000003913 00000 n This antibiotic is active against Gram-positive aerobic and anaerobic bacteria1 2 and is commonly used in hospitals to treat serious infections.3 4 Vancomycin has slow bactericidal time-dependent activity and can be administered by continuous or . Unwarranted therapy with parenteral iron will cause excess storage of iron with the consequent possibility of exogenous hemosiderosis. Off-label: Use is not currently included in the labeling approved by the US Food and Drug Administration. Such reactions may be immediate or delayed. . 0000005561 00000 n The total volume of Infed required for the treatment of iron replacement for blood loss is determined from an appropriate formula listed [see Dosage and Administration (2.3)]. Ling J, Gupta VD. Administer a test dose of Infed prior to administration of therapeutic dose [see Dosage and Administration (2.4)]. government site. Patheon Italia S.p.A. HR0~